Clinical trials
Age clinical trials
Below are recruiting age clinical trials, each written for real people, not researchers. We’re tracking 1,309 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04853251RecruitingPhase 4
Study of corneal cells after a ranibizumab eye implant
This trial checks how well corneal endothelial cells (cells that help keep the cornea clear) do in people with neovascular age-related macular degeneration (nAMD) who are treated with a port-delivery implant that releases ranibizumab. It also helps doctors understand whether this method changes corneal health and stays safe while controlling the eye disease.
Mesa, ArizonaAges 50 years+ - NCT06765980RecruitingPhase 1/Phase 2
Study of KRIYA-825 for geographic atrophy in age-related macular degeneration
This trial tests an experimental drug called KRIYA-825 (also known as VV-14295) for people with geographic atrophy, a late stage of dry age-related macular degeneration that causes vision loss. The study aims to see if the treatment is safe and can help slow the progression of the disease.
Erie, PennsylvaniaAges 55–80 - NCT06660706Recruiting
Exercise study for older adults with slow walking or weak grip
This study tests whether a supervised exercise program can help improve muscle strength and overall health in people aged 65 and older. It also looks for certain markers in the blood that may be linked to the benefits of exercise.
TaipeiAges 65 years+ - NCT02339012Recruiting
Genetic study of healthy and frail aging
This study looks at genes and aging by comparing healthy people, those who are not healthy or frail, and those who are frail. You'll provide blood samples and get MRI scans to help researchers understand aging better.
Baltimore, MarylandAges 20–120 - NCT06229093Recruiting
Music study for healthy brain aging
This trial tests whether listening to specially designed music can help keep your brain healthy as you age. You'll listen to music at home and complete thinking and memory tasks to see if it makes a difference.
Boston, MassachusettsAges 18–95 - NCT07317934RecruitingPhase 3
Gene therapy for wet age-related macular degeneration
This study tests a one-time gene therapy called LX102 for wet age-related macular degeneration (AMD). It may reduce the need for frequent eye injections and help preserve vision.
Hefei, AnhuiAges 50–80 - NCT06813261Recruiting
GLYLO supplement trial for aging in postmenopausal women
This trial tests whether a supplement called GLYLO can reduce markers of aging related to sugar damage in postmenopausal women. It may help if you are between 45 and 65, have some extra belly fat or higher blood sugar, and are not taking certain medications.
Novato, CaliforniaAges 45–65 - NCT06629766Recruiting
Study on how father's age affects embryo growth
This study looks at how the father's age might affect the growth of embryos in the lab. It is for couples doing their first IVF cycle, planning to test embryos for genetic health before freezing them, and then transferring one healthy embryo.
Basking Ridge, New JerseyAges 18–41 - NCT06632145Recruiting
A health promotion program for older adults with memory changes
This study tests a group program called Cog-Fun Ageing that helps older adults with memory changes stay active and healthy. If you have mild memory issues but can still think clearly, you may be able to join this Hebrew-speaking program.
JerusalemAges 60 years+ - NCT06520982RecruitingEarly Phase 1
Early brain and blood vessel changes in aging women
This study looks at how blood vessels in the brain change as women age. It may help understand why some women have higher risk for certain health problems later in life.
Columbia, MissouriAges 18–70 - NCT06527066Recruiting
Aromatherapy for aging skin: a pilot study
This study tests whether a special aromatherapy oil applied to the face can help reduce signs of aging like wrinkles and fine lines. If you are a woman between 45 and 55 with mild to moderate skin aging, this study may be a good fit for you.
São Paulo, São PauloAges 45–55 - NCT06031727RecruitingEarly Phase 1
CRISPR gene therapy for wet age-related macular degeneration
This trial tests a new CRISPR-based treatment for wet age-related macular degeneration (AMD). It aims to stop vision loss by targeting the cause of abnormal blood vessel growth in the eye. This study is for people who have already tried anti-VEGF injections but might not be responding well enough.
Shanghai, Shanghai MunicipalityAges 50–80 - NCT05319067Recruiting
Gut bacteria study in toddlers on long-term reflux antibiotics
This study compares gut bacteria (microbiome) in toddlers who take an antibiotic to prevent urine infections for vesicoureteral reflux, versus other similar children. It may help researchers understand how long-term antibiotic use and reflux affect gut health and future risk.
MontpellierAges 1–3 - NCT05240885Recruiting
Study how aging and health affect body function and metabolism
This trial studies how the body changes with aging in both healthy people and people with health conditions. It may help researchers better understand what affects physical function and metabolism over time.
College Station, TexasAges 50 years+ - NCT05562947RecruitingPhase 3
Ranibizumab port implant for wet macular degeneration in Chinese adults
This Phase 3 study tests whether a small eye implant that delivers medicine on a schedule (the port delivery system) with ranibizumab works better and safely in people with wet age-related macular degeneration. It’s designed for patients who have already been treated recently with anti-VEGF injections and need continued control.
BeijingAges 50 years+ - NCT05483465RecruitingPhase 4
NAD supplement trial for brain blood vessel health in aging
This trial studies whether taking an NAD supplement can support brain blood vessel health as people age. Participants will be tested for brain and health changes and may help researchers understand how to keep the brain’s blood vessels healthier over time.
Oklahoma City, OklahomaAges 60–85 - NCT03972345Enrolling by invitation
Study on how sticking to growth hormone affects near adult height
This study looks at whether consistently taking growth hormone (Norditropin) helps children reach a height goal by “near final height.” It focuses on children who are short due to growth hormone deficiency or born small for gestational age.
UlmAges birth–15 years - NCT04627428RecruitingPhase 1/Phase 2
Stem-cell–made eye tissue transplant for dry macular degeneration
This early-stage study tests whether a stem-cell–derived transplant to the back of the eye is safe and tolerable in people with dry age-related macular degeneration (AMD). If you qualify, you may receive the transplant and have close follow-up to watch for side effects.
Beverly Hills, CaliforniaAges 55 years+ - NCT05598112RecruitingEarly Phase 1
Oral stool-based microbiome treatment for healthy aging
This early-stage study tests whether changing the gut bacteria using an oral stool-based treatment (called oral FMT) can improve health in older adults. It aims to see if this approach affects aging-related changes, including gut and body function.
Beijing, Beijing MunicipalityAges 70–85 - NCT06066775Recruiting
Glucose, fats, and brain health in aging
This study looks at how blood sugar and fat levels relate to brain aging over time. It may help understand why some people's brains age faster than others.
Jinan, ShandongAges 50 years+ - NCT07664280Recruiting
Facial acupuncture for skin aging
This study tests whether a single session of facial acupuncture can improve your skin's structure and how satisfied you are with your appearance. If you are concerned about facial aging and are in good general health, you may be able to join.
TaipeiAges 30–60 - NCT06213038RecruitingPhase 1
Study of SKG0106 for wet age-related macular degeneration
This study tests a new medicine called SKG0106, given as an injection into the eye, for people with wet age-related macular degeneration (AMD). It aims to see if it is safe and effective in treating the leaky blood vessels that cause vision loss.
BeijingAges 50 years+ - NCT06269939Recruiting
Memory training for healthy aging and mild memory loss
This study tests a special memory training program for people with mild memory problems (MCI) or healthy aging. It aims to improve how you learn and remember new information using guided methods.
East Hanover, New JerseyAges 60 years+ - NCT07513298Recruiting
Video Game Exercise for Overweight Children's Fitness
This study tests whether playing specially designed Wii video games that involve aerobic exercise can help overweight children improve their reaction time and lung function. The goal is to see if gaming-based exercise can be an engaging way for kids to get healthier.
CairoAges 10–15
Hear when a new Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for age?
- Yes. Clin2 currently lists 1,309 recruiting age studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a age trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a age trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.